Cadila Healthcare gets FDA nod for arthritis drug - (Business Line via NewsPoints Desk)

  • Zydus Cadila said that it received FDA approval to market the arthritis drug etodolac, Business Line reported Thursday.
  • The company noted that the therapy is used to treat juvenile arthritis, rheumatoid arthritis and osteoarthritis.

To read more NewsPoints articles, click here.

Reference Articles